The FDA has approved an expanded indication for luspatercept (Reblozyl) for the first-line treatment of anemia in patients with low-risk MDS who may require blood transfusions. “For patients with ...

Anemia and thrombocytopenia cause low levels of red blood cells and platelets. This can cause fatigue and bleeding problems. Thrombocytopenia is a low platelet count. Platelets, also known as ...

Peter L. Salgo, MD: I was going to ask what the standard of care is, but I think you’re answering me: The standard of care shifts. Daniel W. Coyne, MD: There is none. If there’s any standard, it’s a ...

LONDON--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk ...

Chemotherapy-induced anemia develops when chemotherapy drugs damage bone marrow cells that create red blood cells, reducing oxygen circulation throughout your body. About 70% of people receiving ...

Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and regulates iron metabolism. Additional data are needed regarding the effectiveness and ...

Sickle cell anemia is the most severe form of sickle cell disease (SCD). Treatments for sickle cell anemia include medications, blood transfusions, and bone marrow transplants. SCD is a group of ...

A 50-year-old woman was admitted to the hospital because of vaginal bleeding and anemia. She had a history of fibroids and 1 ...

The goal in treating anemia in chronic kidney disease (CKD) is to help your body make more healthy red blood cells. The exact treatment you'll get depends on what causes your anemia and your symptoms.